Kansas City, KS – As a nurse at The University of Kansas Health System, Bailea Hoetmer never imagined becoming a cancer patient herself. In her 30s, she noticed blood in her stool, leading to a stage 4 colon cancer diagnosis. After surgery, 29 rounds of chemotherapy and additional treatments, she now has no evidence of disease. On Morning Medical Update, Bailea shares her journey, and doctors explain why colorectal cancer is increasingly affecting younger adults and the warning signs no one should ignore.
Baliea Hoetmer, Patient, Registered Nurse, The University of Kansas Health System
- Baliea’s colonoscopy revealed a large mass in her ascending colon, leading to a stage 4 cancer diagnosis.
- She underwent surgery and 29 rounds of chemotherapy, with changes to her treatment plan after cancer was found in her liver.
- She received immunotherapy and radiation, as well as microwave ablation.
- She is currently considered to have no evidence of disease (NED), while acknowledging the emotional challenges and ongoing worry about recurrence.
Dr. Raed Al-Rajabi, Medical Oncologist, The University of Kansas Cancer Center
- Dr. Al-Rajabi discusses Bailea's stage 4 colon cancer diagnosis and the aggressive, multidisciplinary approach used to treat her disease.
- He explains how chemotherapy, immunotherapy and other treatments may be combined or adjusted as a patient's cancer responds or progresses.
- He discusses colorectal cancer warning signs, including blood in the stool, changes in bowel habits and persistent abdominal symptoms.
- Dr. Al-Rajabi addresses screening recommendations, risk factors and why people experiencing concerning symptoms should seek medical evaluation regardless of age.
Dr. Ben Martin, Colon and Rectal Surgeon, The University of Kansas Health System
- Dr. Martin explains the role of surgery in colorectal cancer treatment and how the approach depends on the location and stage of the disease.
- He addresses potential risk factors, including family history, genetics, diet and other lifestyle considerations.
- He discusses colorectal cancer screening, including the recommendation that average-risk adults generally begin screening at age 45.
- He explains why persistent symptoms should not be ignored simply because someone is younger than the recommended screening age.
